摘要 |
<p>The present invention relates to ethynyl derivatives of formula I wherein X is N or C-R, wherein R is hydrogen or halogen; G is N or CH; with the proviso that maximum one of G or X can be nitrogen; R<sup>1</sup> is phenyl or pyridinyl, which are optionally substituted by halogen; R<sup>2</sup> is hydrogen, lower alkyl, hydroxy, lower alkoxy or C(O)O-benzyl; R<sup>3</sup>,R<sup>3'</sup>, R<sup>4</sup>, R<sup>4</sup>, R<sup>6</sup>, R<sup>6'</sup> are independently from each other hydrogen or lower alkyl; or R<sup>6</sup> and R<sup>4</sup> may form together with the carbon atom to which they are attached a C4-6-cycloalkyl ring, if m is 0 and n is 1 or 2; R<sup>5</sup> is hydrogen or lower alkyl; n is 0, 1 or 2; m is 0 or 1; with the proviso that n and m are not simultaneously 0; or to a pharmaceutically acceptable acid addition salt, to a racemic mixture, or to its corresponding enantiomer and/or optical isomer and/or stereoisomer thereof. It has now surprisingly been found that the compounds of general formula I are positive allosteric modulators (PAM) of the metabotropic glutamate receptor subtype 5 (mGluR5). They may be used for the treatment of schizophrenia or cognitive disorders.</p> |